| Product Type | Impurity Standards |
| CAT. No. | MRL-E33015 |
| CAS. No. | 184972-12-1 |
| Mol. Formula | C20H24O3 |
| Mol. Weight | 312.41 |
| Synonyms | NA |
| Chemical Name | (8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,11,12,13,15,16-octahydrospiro[cyclopenta[a]phenanthrene-6,2\'-oxirane]-3,17(10H,14H)-dione |
| HSN Code | 38229010 |
| Country of Origin | India |
| Stock Status | In Stock |
Epoxy Exemestane (6 Alpha , Beta Isomer) with CAS No.184972-12-1 is an impurity standard of Exemestane Exemestane is a medication classified as an aromatase inhibitor, primarily used in the treatment of hormone receptor-positive breast cancer in postmenopausal women. Aromatase inhibitors work by inhibiting the enzyme aromatase, which is responsible for converting androgens into estrogen. By reducing estrogen levels, exemestane helps to slow down or inhibit the growth of estrogen-dependent breast tumors. It is often prescribed as part of adjuvant therapy or after other treatments like tamoxifen. Exemestane is typically taken orally in tablet form. As with any cancer medication, its use is carefully managed by healthcare professionals based on the specific characteristics of the cancer and the patients overall health. Adverse effects and considerations related to bone health may be discussed with patients taking exemestane, and regular monitoring is typically part of the treatment plan. Buy high quality Epoxy Exemestane (6 Alpha , Beta Isomer) from Molsyns Research. Molsyns Research is one of the leading manufacturer and exporterof Epoxy Exemestane (6 Alpha , Beta Isomer)